FDA issues guidance on use of Bayesian methods to support drug development
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)Clinical TrialsPDUFAPharmaceuticalsProduct developmentRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)